FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040730864> ?p ?o ?g. }

• W2040730864 endingPage "e11227" @default.
• W2040730864 startingPage "e11227" @default.
• W2040730864 abstract "Background In malaria endemic countries, children who have experienced an episode of severe anaemia are at increased risk of a recurrence of anaemia. There is a need to find ways of protecting these at risk children from malaria and chemoprevention offers a potential way of achieving this objective. Methods During the 2003 and 2004 malaria transmission seasons, 1200 Gambian children with moderate or severe anaemia (Hb concentration <7 g/dL) were randomised to receive either monthly sulfadoxine-pyrimethamine (SP) or placebo until the end of the malaria transmission season in which they were enrolled, in a double-blind trial. All study subjects were treated with oral iron for 28 days and morbidity was monitored through surveillance at health centres. The primary endpoint was the proportion of children with moderate or severe anaemia at the end of the transmission season. Secondary endpoints included the incidence of clinical episodes of malaria during the surveillance period, outpatient attendances, the prevalence of parasitaemia and splenomegaly, nutritional status at the end of the malaria transmission season and compliance with the treatment regimen. Results The proportions of children with a Hb concentration of <7 g/dL at the end of the malaria transmission season were similar in the two study groups, 14/464 (3.0%) in children who received at least one dose of SP and 16/471 (3.4%) in those who received placebo, prevalence ratio 0.89 (0.44,1.8) P = 0.742. The protective efficacy of SP against episodes of clinical malaria was 53% (95% CI 37%, 65%). Treatment with SP was safe and well tolerated; no serious adverse events related to SP administration were observed. Mortality following discharge from hospital was low among children who received SP or placebo (6 in the SP group and 9 in the placebo group respectively). Conclusions Intermittent treatment with SP did not reduce the proportion of previously anaemic children with moderate or severe anaemia at the end of the malaria season, although it prevented malaria. The combination of appropriate antimalarial treatment plus one month of iron supplementation and good access to healthcare during follow-up proved effective in restoring haemoglobin to an acceptable level in the Gambian setting. Trial Registration ClinicalTrials.gov NCT00131716" @default.
• W2040730864 created "2016-06-24" @default.
• W2040730864 creator A5001159821 @default.
• W2040730864 creator A5011148563 @default.
• W2040730864 creator A5012387962 @default.
• W2040730864 creator A5027270405 @default.
• W2040730864 creator A5032509572 @default.
• W2040730864 creator A5044222247 @default.
• W2040730864 creator A5044475203 @default.
• W2040730864 creator A5058236091 @default.
• W2040730864 creator A5066467593 @default.
• W2040730864 date "2010-06-21" @default.
• W2040730864 modified "2023-09-26" @default.
• W2040730864 title "Prevention of the Recurrence of Anaemia in Gambian Children Following Discharge from Hospital" @default.
• W2040730864 cites W1838568970 @default.
• W2040730864 cites W1974204803 @default.
• W2040730864 cites W1980965825 @default.
• W2040730864 cites W1995035324 @default.
• W2040730864 cites W1998302348 @default.
• W2040730864 cites W2005705112 @default.
• W2040730864 cites W2036179744 @default.
• W2040730864 cites W2042094287 @default.
• W2040730864 cites W2044007531 @default.
• W2040730864 cites W2069358137 @default.
• W2040730864 cites W2073616642 @default.
• W2040730864 cites W2076050345 @default.
• W2040730864 cites W2094710221 @default.
• W2040730864 cites W2098161375 @default.
• W2040730864 cites W2104840405 @default.
• W2040730864 cites W2105748597 @default.
• W2040730864 cites W2114186504 @default.
• W2040730864 cites W2121762116 @default.
• W2040730864 cites W2123310297 @default.
• W2040730864 cites W2124971883 @default.
• W2040730864 cites W2130756979 @default.
• W2040730864 cites W2138132137 @default.
• W2040730864 cites W2138888301 @default.
• W2040730864 cites W2144422782 @default.
• W2040730864 cites W2147895892 @default.
• W2040730864 cites W2156877149 @default.
• W2040730864 cites W2159865605 @default.
• W2040730864 cites W2219361567 @default.
• W2040730864 cites W2276365157 @default.
• W2040730864 cites W2322213143 @default.
• W2040730864 cites W2413878195 @default.
• W2040730864 cites W2423378656 @default.
• W2040730864 doi "https://doi.org/10.1371/journal.pone.0011227" @default.
• W2040730864 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2888645" @default.
• W2040730864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20574541" @default.
• W2040730864 hasPublicationYear "2010" @default.
• W2040730864 type Work @default.
• W2040730864 sameAs 2040730864 @default.
• W2040730864 citedByCount "16" @default.
• W2040730864 countsByYear W20407308642012 @default.
• W2040730864 countsByYear W20407308642013 @default.
• W2040730864 countsByYear W20407308642015 @default.
• W2040730864 countsByYear W20407308642018 @default.
• W2040730864 countsByYear W20407308642020 @default.
• W2040730864 countsByYear W20407308642021 @default.
• W2040730864 countsByYear W20407308642022 @default.
• W2040730864 countsByYear W20407308642023 @default.
• W2040730864 crossrefType "journal-article" @default.
• W2040730864 hasAuthorship W2040730864A5001159821 @default.
• W2040730864 hasAuthorship W2040730864A5011148563 @default.
• W2040730864 hasAuthorship W2040730864A5012387962 @default.
• W2040730864 hasAuthorship W2040730864A5027270405 @default.
• W2040730864 hasAuthorship W2040730864A5032509572 @default.
• W2040730864 hasAuthorship W2040730864A5044222247 @default.
• W2040730864 hasAuthorship W2040730864A5044475203 @default.
• W2040730864 hasAuthorship W2040730864A5058236091 @default.
• W2040730864 hasAuthorship W2040730864A5066467593 @default.
• W2040730864 hasBestOaLocation W20407308641 @default.
• W2040730864 hasConcept C120665830 @default.
• W2040730864 hasConcept C121332964 @default.
• W2040730864 hasConcept C126322002 @default.
• W2040730864 hasConcept C142724271 @default.
• W2040730864 hasConcept C187212893 @default.
• W2040730864 hasConcept C203014093 @default.
• W2040730864 hasConcept C204787440 @default.
• W2040730864 hasConcept C27081682 @default.
• W2040730864 hasConcept C2777035104 @default.
• W2040730864 hasConcept C2777425658 @default.
• W2040730864 hasConcept C2778048844 @default.
• W2040730864 hasConcept C2778301690 @default.
• W2040730864 hasConcept C2781413609 @default.
• W2040730864 hasConcept C61511704 @default.
• W2040730864 hasConcept C71924100 @default.
• W2040730864 hasConceptScore W2040730864C120665830 @default.
• W2040730864 hasConceptScore W2040730864C121332964 @default.
• W2040730864 hasConceptScore W2040730864C126322002 @default.
• W2040730864 hasConceptScore W2040730864C142724271 @default.
• W2040730864 hasConceptScore W2040730864C187212893 @default.
• W2040730864 hasConceptScore W2040730864C203014093 @default.
• W2040730864 hasConceptScore W2040730864C204787440 @default.
• W2040730864 hasConceptScore W2040730864C27081682 @default.
• W2040730864 hasConceptScore W2040730864C2777035104 @default.
• W2040730864 hasConceptScore W2040730864C2777425658 @default.
• W2040730864 hasConceptScore W2040730864C2778048844 @default.

• next